This course has expired. View available courses.
Geriatrics, Cardiology
Interactive Case Studies in Anticoagulants: The role of DOACs in managing AF in patients with complex comorbidities
Atrial fibrillation (AF) is the most common recurrent arrhythmia in clinical practice and the prevalence increases steeply with age, and with common age-associated co-morbidities such as heart failure, coronary artery disease, obesity, hypertension, diabetes and chronic kidney disease. It is associated with increased risk of serious morbidities such as stroke and with death. Current clinical […]
DURATION
35 min.
PROFESSION
Physician, Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-01-28
Atrial fibrillation (AF) is the most common recurrent arrhythmia in clinical practice and the prevalence increases steeply with age, and with common age-associated co-morbidities such as heart failure, coronary artery disease, obesity, hypertension, diabetes and chronic kidney disease. It is associated with increased risk of serious morbidities such as stroke and with death.
Current clinical guidelines recommend direct oral anticoagulants (DOACs) as the treatment of choice to reduce stroke risk in non-valvular AF (NVAF). It is important for clinicians to be confident prescribing these drugs in the spectrum of patients with NVAF.
This program will help improve your skills and knowledge when prescribing DOACs for complex older patients with NVAF in the presence of co-morbidities and polypharmacy, while taking into account and mitigating important risks, such as bleeding and considering appropriate drug selection and dose adjustment.
This program is supported by an independent and unrestricted educational grant by BMS Alliance & Pfizer.
Faculty
Professor Andrew Sindone, B.Med (Hons), MD (UNSW), FRACP, FCSANZ, FNHFA
Director Heart Failure Unit and
Department of Cardiac Rehabilitation Concord Hospital and
Head of Department of Cardiology, Ryde Hospital
A/Prof Charles Denaro, MBBS (1st Class hons), FRACP, MD (Research) PSM
Director, Department of Internal Medicine & Aged Care
Royal Brisbane & Women's Hospital
Associate Professor of Medicine, University of Queensland
Dr Maria Dellamalva, MBBS FRACP
Royal Adelaide Hospital and Memorial Medical Centre and
Senior Clinical Lecturer University of Adelaide
Learning objectives
Upon completion of this continuing education program clinicians will be better able to:
- Manage complex, older patients with NVAF and multiple co-morbidities and polypharmacy, in accordance with current clinical guidelines
- Prescribe DOACs appropriately for patients with NVAF, including drug selection and dose adjustment in accordance with patient factors such as age, weight, renal function and bleeding risk